Stevanato Group (NYSE:STVN – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.700-0.720 for the period, compared to the consensus estimate of 0.680. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.
Analysts Set New Price Targets
STVN has been the subject of several recent research reports. Wolfe Research began coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective for the company. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Finally, TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Stevanato Group has a consensus rating of “Buy”.
View Our Latest Research Report on Stevanato Group
Stevanato Group Stock Down 0.1%
Stevanato Group (NYSE:STVN – Get Free Report) last announced its earnings results on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.56%. The business had revenue of €273.57 million for the quarter. During the same period in the previous year, the company earned $0.10 EPS. Stevanato Group’s quarterly revenue was up 6.6% on a year-over-year basis. On average, sell-side analysts predict that Stevanato Group will post 0.71 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Stevanato Group news, Director Karen Flynn sold 1,493 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the transaction, the director directly owned 5,757 shares of the company’s stock, valued at €98,387.13. This represents a 20.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William J. Federici sold 1,493 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the sale, the director directly owned 26,991 shares of the company’s stock, valued at €461,276.19. The trade was a 5.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 5,972 shares of company stock valued at $102,061 over the last 90 days. 0.70% of the stock is owned by company insiders.
Hedge Funds Weigh In On Stevanato Group
A number of hedge funds have recently bought and sold shares of STVN. Norges Bank acquired a new position in shares of Stevanato Group during the fourth quarter worth approximately $8,185,000. Credit Agricole S A bought a new stake in Stevanato Group during the 3rd quarter valued at $9,785,000. T. Rowe Price Investment Management Inc. grew its stake in shares of Stevanato Group by 10.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after purchasing an additional 368,792 shares in the last quarter. Heights Point Management LP bought a new position in shares of Stevanato Group in the fourth quarter worth $5,544,000. Finally, Bank of America Corp DE increased its holdings in shares of Stevanato Group by 98.1% during the third quarter. Bank of America Corp DE now owns 430,761 shares of the company’s stock valued at $11,092,000 after purchasing an additional 213,340 shares during the period.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Read More
- Five stocks we like better than Stevanato Group
- McDonald’s Stock Sell-Off: Justified Warning or Buying Opportunity?
- Why Brown-Forman Rejected a 23% Premium Twice
- Rocket Lab Lands a Wave of Contracts Ahead of Earnings
- Amprius Technologies Validates Growth Trajectory With Q2 Earnings—What Comes Next?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
